Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Officinal composition for lowering blood fat

A composition and blood lipid-lowering technology, applied in the new field of medicine

Inactive Publication Date: 2010-07-07
BEIJING HOPE HUGE PHARM SCI
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The average plasma half-life of atorvastatin is about 14 hours, but due to the influence of its active metabolite, the actual half-life of HMG-CoA reductase inhibition is 20-30 hours

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Officinal composition for lowering blood fat
  • Officinal composition for lowering blood fat
  • Officinal composition for lowering blood fat

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Embodiment 1: Atorvastatin Probucol Tablets

[0028] prescription:

[0029]

[0030] Preparation:

[0031] Pass the prescription amount of probucol and atorvastatin through 80 mesh sieve respectively, mix evenly, add 30% ethanol solution to the mixed powder, make soft material, 24 mesh sieve, granulate, dry, 20 mesh sieve, granulate, Add micropowder silica gel, CMS-Na. Mix evenly and press into tablets.

[0032] Direct tablet compression method: Mix the raw ingredients and auxiliary materials evenly, sieve, and tablet.

[0033] If the above-mentioned tablets are coated, coated tablets can be obtained, which can be film-coated tablets, enteric-coated tablets, etc.

Embodiment 2

[0034] Embodiment 2: Atorvastatin Probucol Tablets

[0035] prescription:

[0036]

[0037] Preparation:

[0038] Pass probucol, atorvastatin, xylitol, mannitol and other raw and auxiliary materials through a 50-mesh sieve respectively, mix them uniformly by using an equal-volume increasing method, add 3% PVPk-30 ethanol solution, and make a soft material with a 24-mesh sieve Granules, dried, granulated with a 20-mesh sieve, dried, added other flavoring agents, sweeteners, and glidants, mixed evenly, compressed into tablets, and obtained.

Embodiment 3

[0039] Embodiment 3: Atorvastatin Probucol Dispersible Tablets

[0040] prescription

[0041]

[0042] Preparation:

[0043] Pass probucol, atorvastatin and other raw materials through 80-mesh sieve, mix well, add 75% ethanol solution, make soft material, granulate with 16-mesh sieve, dry, granulate with 20-mesh sieve, add other flavoring agents Sweet orange essence, sweetener aspartame, and disintegrant PPVP are mixed evenly, and pressed into tablets to obtain the product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an officinal composition for lowering blood fat. Active ingredients are atorvastatin and probucol. The invention provides a better fat regulating drug for patients clinically suffering from severe lipid metabolism disorders and especially has favorable synergistic effect on patients at high liver function damaging risk level by drug combination; two kinds of drugs complement advantages so as to obviously lower the possibility of side effect occurrence because of increased amount of atorvastatin. The officinal composition for lowering blood fat is prepared from active ingredients and pharmaceutically acceptable supplementary materials, but is not limited in preparations, such as tablets, dispersible tablets, sustained release tablets and the like.

Description

technical field [0001] The invention belongs to the field of new medicine technology and relates to a blood lipid-lowering medicinal composition. Background technique [0002] Hypertension and hyperlipidemia have become a common disease and frequently-occurring disease. [0003] Atorvastatin is a statin blood lipid regulating drug and is an HMG-CoA reductase inhibitor. It itself is inactive, and the hydrolyzate after oral absorption competitively inhibits the rate-limiting enzyme hydroxymethylglutaryl-CoA reductase in the process of cholesterol synthesis in vivo, reducing the synthesis of cholesterol and increasing the synthesis of low-density lipoprotein receptors , the main site of action is in the liver. As a result, blood cholesterol and low-density lipoprotein cholesterol levels are reduced, serum triglyceride levels are moderately reduced, and blood high-density lipoprotein levels are increased. Thus, it has an effect on the prevention and treatment of atherosclerosi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/40A61K31/10A61P3/06
Inventor 王翰斌李玉娟
Owner BEIJING HOPE HUGE PHARM SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com